SynchroPET: Revolutionizing PET Imaging
SynchroPET is a biotechnology innovator advancing research and clinical assessment utilizing Positron Emission Technology (PET). SynchroPET’s technology was developed at Brookhaven National Laboratory, revolutionizing PET Scanners to offer researchers mobility within the laboratory and the potential for instantaneous clinical assessment with combined functional and anatomical imaging. These advances will accelerate the creation of new pharmaceuticals to treat cancer, Alzheimer and Parkinson’s diseases, as well as provide superior imaging technology to make all PET scans more quantitative.
The people behind a company are as important as the company itself. With a passion for advancing technology to better humanity, the SynchroPET team is comprised of leaders in the fields of technology, healthcare, medical devices and engineering.